Eudaimonia Advisors LLC Decreases Stake in Regeneron Pharmac

Eudaimonia Advisors LLC trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 879 shares of the biopharmaceutical company’s stock after selling 20 shares during the quarter. Eudaimonia Advisors […]

Related Keywords

Michaels Brown , Marion Mccourt , Regeneron Pharmaceuticals Profile , Mission Wealth Management , Ef Hutton Acquisition Co , Eudaimonia Advisors , Colonial River Wealth Management , Regeneron Pharmaceuticals , Canaccord Genuity Group , Joel Isaacson Co , Quarter For Regeneron Pharmaceuticals , Jpmorgan Chase Co , Regeneron Pharmaceuticals Inc , Wells Fargo Company , Insider Activity At Regeneron Pharmaceuticals , Quent Capital , Nasdaq , Crescent Sterling Ltd , News Ratings For Regeneron Pharmaceuticals Daily , Regeneron Pharmaceuticals Trading Down , Free Report , River Wealth Management , Wealth Management , Crescent Sterling , Genuity Group , Pharmaceuticals Trading Down , Director Michael , Visit Holdingschannel , Regeneron Pharmaceuticals Daily ,